Liver function, in-hospital, and post-discharge clinical outcome in patients with acute heart failure - Results from the relaxin for the treatment of patients with acute heart failure study

Journal of Cardiac Failure

Volumn 20, Issue 6, 2014, Pages 407-413

  Van Deursen, Vincent M ^a   Edwards, Christopher ^b   Cotter, Gad ^b   Davison, Beth A ^b   Damman, Kevin ^a   Teerlink, John R ^c   Metra, Marco ^d   Felker, G Michael ^e   Ponikowski, Piotr ^f   Unemori, Elaine ^g   Severin, Thomas ^h   Voors, Adriaan A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Momentum Research Inc   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF BRESCIA   (Italy)

^e DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^f WROCLAW MEDICAL UNIVERSITY   (Poland)

^g Corthera ^*  (United States)

^h NOVARTIS PHARMA AG   (Switzerland)

Author keywords

acute decompensated heart failure; Liver function; prognosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; RELAXIN; SERUM ALBUMIN;

ACUTE HEART FAILURE; AGED; ARTICLE; FEMALE; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; LIVER FUNCTION; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEW YORK HEART ASSOCIATION CLASS; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; VERY ELDERLY; ACUTE DISEASE; BLOOD; CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; HEART FAILURE; LIVER; MIDDLE AGED; MULTICENTER STUDY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TRENDS;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITALIZATION; HUMANS; LIVER; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PATIENT DISCHARGE; RELAXIN; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84901785651     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2014.03.003     Document Type: Article

References (18)

1. N. Jolliffe Liver function in congestive heart failure J Clin Invest 8 1930 419 433
2. V.M. van Deursen, K. Damman, H.L. Hillege, A.P. van Beek, D.J. van Veldhuisen, and A.A. Voors Abnormal liver function in relation to hemodynamic profile in heart failure patients J Card Fail 16 2010 84 90
3. L.A. Allen, G.M. Felker, S. Pocock, J.J. McMurray, M.A. Pfeffer, and K. Swedberg et al. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program Eur J Heart Fail 11 2009 170 177
4. G.T. Lau, H.C. Tan, and L. Kritharides Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation Am J Cardiol 90 2002 1405 1409 (Pubitemid 35449493)
5. V.M. van Deursen, K. Damman, P. van der Meer, P.J. Wijkstra, G.J. Luijckx, and A. van Beek et al. Co-morbidities in heart failure Heart Fail Rev 19 2014 163 172
6. A.P. Ambrosy, M. Vaduganathan, M.D. Huffman, S. Khan, M.J. Kwasny, and A.J. Fought et al. Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial Eur J Heart Fail 14 2012 302 311
7. J. Biegus, R. Zymlinski, M. Sokolski, S. Nawrocka, P. Siwolowski, and J. Szachniewicz et al. Liver function tests in patients with acute heart failure Pol Arch Med Wewn 122 2012 471 479
8. M. Nikolaou, J. Parissis, M.B. Yilmaz, M.F. Seronde, M. Kivikko, and S. Laribi et al. Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure Eur Heart J 34 2012 742 749
9. J.R. Teerlink, M. Metra, G.M. Felker, P. Ponikowski, A.A. Voors, and B.D. Weatherley et al. Relaxin for the Treatment of Patients With Acute Heart Failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study Lancet 373 2009 1429 1439
10. L. Felder, A. Mund, and J.G. Parker Liver function tests in chronic congestive heart failure Circulation 2 1950 286 297
11. S.M. Richman, A.J. Delman, and D. Grob Alterations in indices of liver function in congestive heart failure with particular reference to serum enzymes Am J Med 30 1961 211 225
12. S.H. Kubo, B.A. Walter, D.H. John, M. Clark, and R.J. Cody Liver function abnormalities in chronic heart failure. Influence of systemic hemodynamics Arch Intern Med 147 1987 1227 1230 (Pubitemid 17102148)
13. S.D. Russell, J.G. Rogers, C.A. Milano, D.B. Dyke, F.D. Pagani, and J.M. Aranda et al. Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device Circulation 120 2009 2352 2357
14. T.J. White, C.M. Leevy, A.M. Brusca, and A.M. Gnassi The liver in congestive heart failure Am Heart J 49 1955 250 257
15. P. Batin, M. Wickens, D. McEntegart, L. Fullwood, and A.J. Cowley The importance of abnormalities of liver function tests in predicting mortality in chronic heart failure Eur Heart J 16 1995 1613 1618 (Pubitemid 26037793)
16. H. Shinagawa, T. Inomata, T. Koitabashi, H. Nakano, I. Takeuchi, and T. Naruke et al. Prognostic significance of increased serum bilirubin levels coincident with cardiac decompensation in chronic heart failure Circ J 72 2008 364 369 (Pubitemid 351600627)
17. J.J. McMurray, S. Adamopoulos, S.D. Anker, A. Auricchio, M. Böhm, and K. Dickstein et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur J Heart Fail 14 2012 803 869
18. M. Metra, G. Cotter, B.A. Davison, G.M. Felker, G. Filippatos, and B.H. Greenberg et al. Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes J Am Coll Cardiol 61 2013 196 206